Structure-activity relationships of monoamine oxidase inhibitors.
D000818:Animals; D002417:Cattle; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D006168:Guinea Pigs; D006834:Hydrazines / Q000138:chemical synthesis / Q000494:pharmacology; D066298:In Vitro Techniques; D007700:Kinetics; D051379:Mice; D008928:Mitochondria / Q000201:enzymology; D008930:Mitochondria, Liver / Q000201:enzymology; D008954:Models, Biological; D008996:Monoamine Oxidase Inhibitors / Q000138:chemical synthesis* / Q000494:pharmacology; D010293:Pargyline / Q000138:chemical synthesis / Q000494:pharmacology; D011437:Propylamines / Q000138:chemical synthesis / Q000494:pharmacology; D051381:Rats; D012044:Regression Analysis; D012110:Reserpine / Q000494:pharmacology; D013329:Structure-Activity Relationship; D014363:Tryptamines / Q000138:chemical synthesis / Q000494:pharmacology
D006834:Hydrazines; D008996:Monoamine Oxidase Inhibitors; D011437:Propylamines; D014363:Tryptamines; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D010293:Pargyline